Odile Gayet

Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreatic adenocarcinoma

Fabienne Guillaumond, Ghislain Bidaut, Mehdi Ouaïssi et al. · Proceedings of the National Academy of Sciences · 2015 · 464 citations · Full text

Medicine, Oncology, Pharmacology +17

Distinct epigenetic landscapes underlie the pathobiology of pancreatic cancer subtypes

Gwen Lomberk, Yuna Blum, Rémy Nicolle et al. · Nature Communications · 2018 · 277 citations · Full text

Medicine, Cancer Biology, Oncology +17

Gating of Sema3E/PlexinD1 Signaling by Neuropilin-1 Switches Axonal Repulsion to Attraction during Brain Development

Sophie Chauvet, Samia Cohen, Yutaka Yoshida et al. · Neuron · 2007 · 249 citations · Full text

Life Sciences, Neurobiology, Neuroscience +16

Pancreatic Adenocarcinoma Therapeutic Targets Revealed by Tumor-Stroma Cross-Talk Analyses in Patient-Derived Xenografts

Rémy Nicolle, Yuna Blum, Laëtitia Marisa et al. · Cell Reports · 2017 · 196 citations · Full text

Medicine, Cancer Biology, Oncology +17

Targeting Mitochondrial Complex I Overcomes Chemoresistance in High OXPHOS Pancreatic Cancer

Rawand Masoud, Gabriela Reyes‐Castellanos, Sophie Lac et al. · Cell Reports Medicine · 2020 · 184 citations · Full text

Medicine, Oncology, Pharmacology +15